Multiplicity activation of herpes simplex virus in mouse neuroblastoma (C1300) cells
- PMID: 6275823
- DOI: 10.1007/BF01320249
Multiplicity activation of herpes simplex virus in mouse neuroblastoma (C1300) cells
Abstract
The virus yields and number of infectious centres of HSV infected mouse neuroblastoma C1300 cells (clone 41 A3) infected at different multiplicities of infection (MOI) were found to vary more than the differences of HSV concentrations of the virus suspensions used for infection of the cells. This suggested that a C1300 cell had to be infected with more than one HSV particle in order to produce progeny virus-multiplicity activation. The greater than expected enhancement of virus production of C1300 cell cultures receiving increasing MOI of HSV was probably not due to improved virus adsorption, nor influenced by non-virus factors in the virus inoculum stimulatory for HSV replication. A hypothesis, that the block in virus replication was promoted by an inhibitor of an HSV specified regulatory protein and could be overcome by the addition of HSV DNA copies in the infected cell, was by the results of two types of experiments. Presence of phosphonoformic acid, an inhibitor of the HSV specified DNA polymerase, in the culture medium of HSV infected permissive GMK cells resulted in non-linear relationships between virus yields and MOI. An HSV temperature sensitive mutant (ts B5), defective in a late structural protein, rescued wild type HSV in C1300 cells.
Similar articles
-
Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells.Arch Virol. 1985;83(3-4):319-25. doi: 10.1007/BF01309927. Arch Virol. 1985. PMID: 2982359
-
Amplification of herpes simplex virus resistance in mouse neuroblastoma (Cl300) cells.Arch Virol. 1985;83(3-4):269-83. doi: 10.1007/BF01309922. Arch Virol. 1985. PMID: 2578786
-
A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.Antiviral Res. 1981 Nov;1(4):225-35. doi: 10.1016/0166-3542(81)90013-9. Antiviral Res. 1981. PMID: 6280607
-
Herpes simplex virus infection of in vitro cultured neuronal cells (mouse neuroblastoma C 1300 cells).J Gen Virol. 1978 May;39(2):321-32. doi: 10.1099/0022-1317-39-2-321. J Gen Virol. 1978. PMID: 206658
-
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.Am J Med. 1982 Jul 20;73(1A):138-42. doi: 10.1016/0002-9343(82)90079-1. Am J Med. 1982. PMID: 6285703 Review.
Cited by
-
Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells.Arch Virol. 1985;83(3-4):319-25. doi: 10.1007/BF01309927. Arch Virol. 1985. PMID: 2982359
-
Inhibition of herpes simplex virus production in vitro by cyclosporin A.Arch Virol. 1992;122(1-2):61-75. doi: 10.1007/BF01321118. Arch Virol. 1992. PMID: 1309645
-
Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.J Virol. 1987 Jul;61(7):2311-5. doi: 10.1128/JVI.61.7.2311-2315.1987. J Virol. 1987. PMID: 3035230 Free PMC article.
-
Innate and adaptive immune responses to herpes simplex virus.Viruses. 2009 Dec;1(3):979-1002. doi: 10.3390/v1030979. Epub 2009 Nov 18. Viruses. 2009. PMID: 21994578 Free PMC article.
-
Amplification of herpes simplex virus resistance in mouse neuroblastoma (Cl300) cells.Arch Virol. 1985;83(3-4):269-83. doi: 10.1007/BF01309922. Arch Virol. 1985. PMID: 2578786